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The detection of an intermediate in the metabolism .of tryptophan 
occur.rea before the discovery of the amino acid itself when Liebig identi-
fied kynurenic acid in 1853 (1). Since the detection of tryptophan in 
1902 (2) the knowledge of its metabolic fates has become so extensive and 
diverse that a comprehensive review of the entire field must be omitted 
to allow a more thorough survey of the literature pertinent to the re-
search to be reported here. The classic observation by Krehl, et al. 
(3) that tryptophan could serve as a source of niacin in the rat eventually 
led to the establishment of the main pathwey of degradation shown in 
Fig. 1. Despite the early recognition of the tryptophan-niacin relation-
ship, it has never 'been possible to demonstrate the formation of niacin 
in vitro. 3-Bydro::xyanthranilic acid seems to be one of its immediate 
precursors, but only limited information has been obtained concerning 
its metabolism. 
B. 3-Hydroxyanthranilic Acid 
1. DiscoverY and Properties 
In studies on the tryptophan-niacin relationship in Neurospora 
crassa Bonner and Beadle (4) isolated five mutant strains of the mold 
which required niacin, nicotinamide or some related compound for growth. 
Neurospora strain 4540 accumulated a substance which would replace 
nicotinic acid for growth of a second strain 39401. This compound 
was believed to be a direct precursor of niacin. In 1948 Mitchell 
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and Nye ( 5) found 3-bydro:xyanthranilic acid (30HAA) to be 70 per 
cent as effective as nicotinamide in supporting the growth of another 
Neurospora mutant. Bonner (6) identified this acid as the precursor 
of niacin in strain 39401. The compound was also found to have a 
niacin-replacing effect on the growth of rats (7,8) and to cause 
an increase in excretion of urinary N~--metbylnicotinamide, a metabolite 
of niacin ( 9) • 3-Hydro:xyanthra.nilic acid fluo:r. 1sces under the 
influence of ultraviolet light (10,11) and has absorption maxi.ma 
at 298 mµ. at plfl1 (5) and .317 mµ. at pH 7.4 (12). It has been reported 
. to posses cfrcinogenic properties, causing bladder cancer in a 
significant percentage of mice (13). 
2. ,l:Iiydroxvanthranilate as a Precursor in the Formation of 
The f.Yridine Carboxvlic Acids. 
In Vivo 
A roridine C:a\rbo:xylic acid which possessed niacin-replacing 
activity for the growth of Lactobacillus arabinosfls (17-5) when 
heated with glacial acetic acid was identified as quinolinic acid 
by Henderson (14,15). When tryptophan was fed or administered by 
stomach tube to rats there was an increase in quinolinate excretion. 
It was shown that microflora did not effect this conversion (16). 
Henderson later reported that 39HAA as well as t:ryptophan caused 
an increase in urinary quinolinio acid. The B,1-methylnicotinamlde 
and niacin content of the urine also increased (17). Isotopic data 
have since confirmed this metabolic pathway and have shed light on 
the.mechanism of interconversion of these compounds. Shayer and 
Henderson (18) synthesized tryptophan labeled with deuterium in the 
four positions at the benzene ring (C-4,5,6 and 7) and with nitrogen-
15 in the indole ring and injected it intraperitoneally into rats. 
The quinolinic acid isolated from the urine contained both isotopes, 
but the ratio of deuterium to ni trogen-15 was only half that in the 
tryptophan indicating that two of the four deuterium atoms were lost 
in the metabolic degradation. Liefer O et al •. 7 (19) suggested that 
some of the nitrogen of quinolinic acid originated from a.rru:no:oium 
ion in the media. When Neurospora strains were grown in the presence 
of 30HA.A and Nl5-amrnonium chloride, 50 per cent of the nitrogen 
of quinolinic acid was labeledo Yanofsky and Bonner (20), however, 
reported that the isotope incorporation was the result of 30HAA 
synthesis de novo, since resting cells did not catalyze any incor-
poration of nitrogen-15 into quinolinic acid. Hankes and Henderson 
(21) and Hankes and Urivetsky (22) showed that 30HAA labeled in the 
carbo:xyl positio~ with carbon-14, when injected into rats intra-
peritoneally or subcutaneously, gave rise to Nl-metbylnicotinamide 
and quinolinic acid ~cl4 in the urine. Wilson and Henderson 
demonstrated a similar conversion of tritium-labeled 30HAA to 
quinolinic and nicotinic acid in the developing chick embryo (2.3). 
It is possible that quinolinic acid is the immediate 
precursor of niacin. The observations of Mitchell and coworkers 
(5,7), Bonner (6) and .Albert; et al.:, (9) established 30HAA a.a a 
precursor of niacin in Neurospora and in the rat in vivo. Decker 
and Henderson (24) demonstrated that this compound ·;c-an: replace 
niacin for growth in the diets of chicks, hamsters and guinea pigs. 
Quinolinic acid was thought to be a product of a side reaction of 
4 
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30HAA oxidation and was reported not to serve as a source of niacin (4) • · 
I 
In 1947, however, it was found that quinolinic acid increased the 
urinary excretion of Nl·-methynicotinamide when fed to rats and mice 
(25). Henderson also reported this finding and showed that quinolinic 
acid would support growth for the rat and Neurospora 4540 (1 7) • 
The results were later confirmed by Krehl , et aJ. o .'.,' ( 26) and Yanofsky J 
et aJ.o? (20). Hankes and SegaJ. (27) demon~trated that tritium-
labeled quinolinic acid could be converted to Nl-methylnicotinamide in 
the intact rat, and Wilson and Henderson (23) showed a conversion of 
tritium-labeled quinolinate to nicotinic acid in the chick embryo. 
A conclusive demonstration of the decarbo:xylation of quinolinic acid 
to niacin or Nl-metby:1icotina11ide has not been reported in vitro. 
Formation of niacin from 30HAA is not the only route of 
synthesis of the vitamin. Yanofsky (28) showed that tryptophan 
uniformly labeled with carbon-14 did not give labeled niacin in 
Escherichia coli or Bacillus subtilis. Henderson, et ·al.., (29) 
al.so reported the lack of a tryptopha.n-nia.cin relationship in corn 
and tobacco:-plants, and Griffith and Byerrum (.30) have since shown 
that the pyrLdine ring of nicotine8 known to arise from nicotinic 
acid (31), is synthesized from acetate and pyruvate in Nicotia,n.a 
rl!§tica, L. Also, Ortega and Brown (32) demonstrated that E. coli 
synthesized nicotinic acid from glycerol. The carbon-14 from glyceiol-
1, .3-Q14 was incorporated into the pyridine ring. 
Picolinic acid, another pyridihecsrbo:xylic acids:: wa~ 
identified as a metabolite of .30HAA in vitro by Mehler. Mehler and Mey 
injected ca.rbo:xyl-cl4 labeled .30HAA intra.peritoneally into rats 
and observed that 90 per cent of the isotope was expired as cl402 
within the first 24 hours (34). Since picolinic acid was not 
metabolized by the rat, they suggested that this acid was the 
principal metabolite of JOH.A.Ao fuhadolnik et al., however, found 
that only 3 per cent of the tritium. appeared in the urine of the 
rat as picolinic acid or its conjugates when tritium-labeled 
30HAA was administered intraperitoneally, and 14 per cent of the 
isotope was found in the quinolinic acid. Neither quinolinic nor 
picolinic acid was a major product in the metabolism of 30HP~~ 
in vivo (35L 
In Vitro 
Schweigert (36) found that nicotinic acid activity for 
Lactobacillus arabinosus increased 8 per cent in the incubation 
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mixture when 30HAA was incubated with rat liver slices. Henderson 
observed that quinolinic acid was decarboxylated under the conditions 
used by Schweigert to remove the bound nicotinic acid (14)o He suggested 
that 30HAA was oxidatively cleaved in the 3 and 4 positions of the 
benzene ring and recyclized to form quinolinic acid and not 
nicotinic acido Henderson and Ramasarma (37) later reported 
a quantitative conversion of 30HAA to quinolinate in rat liver 
homogenates. Schweigert and Marquette (38) made the same 
observation and suggested an oxygen requirement for the reaction. 
Studies with isotopes have verified this finding (35~39)0 Bokman 
and Schweigert (10) found that the enzyme catalyzing the oxidative 
reaction was present in an acetone powder of liver. Both kidney 
and liver (40j41) of the rat, pig and bovine contained the enzyme. 
7 
Suhadolnik 5 et al. (35) reported that liver extracts of ten species 
of mmmnals contained the oxidase, but there was considerable variation 
in the aIUount of this enzyme and the picolinic acid carboxylase present. 
The oxidation product of 30HAA was reported by Bokman and 
Schweigert (12). As the substrate disappeared a concomitant increase 
in absorption at 3tD mµ was observed. This was show. to be the 
absorption maxirnum of the product; the molar extinction coefficient 
was first reported to be about 20,000. Mineral acid caused a shift 
in the maxi:rnu.rn to 315 mµ, Miyake. et al. (42) and Long;. et al. (11) 
provided further evidence for the participation of this intermediate 
in the oxidation of 30HAA. Long and coworkers showed that the 
disappearance of substrate was accompanied by the appearance of the 
3ED mµ absorbance and by the uptake of one mole of oxygen per mole 
of 30HAA. Quinolinic acid appeared to be the product of the 
spontaneous decey of the intermediate, since theore Gical mnounts 
of quinolinate were produced as the absorption disappeared even after 
removal of the protein with 90 per cent ethanol. Hayaishi, et al. 
(43) have show. that the oxidation requires molecular oxygen rather 
than water, since the isotope from 0 218, not H2ol8, was incorporated 
into the Y-carboxyJ. group of quinolinic acid. They classified the 
enzyme as a "phenolytic oxygenasen (.44). 
Inhibitors and Cofactors 
A dialyzable, heat-stable cofactor for the enzyme was 
reported by Henderson (45). Long (11) and Miyake (42) reported 
that this factor was ferrous ion. Stevens (46) __ and_ L9_ng h~ve shown 
this t.o·beQnabsolute requirement; substitution of other ions often 
caused an inhibition of the reaction rather than activat:j.on. The 
enzyme is· inhibited by etbylenediaminetetraacetic acid (varsene), 
ex, a.1:.. dipyridyl and 2.-phenant:br.oline (11., 42). probably by chelation 
with the ferrous ions. Miyake (42), Mehler (.3.3) and Stevens (47) 
reported that the enzyme was sensitive to sul.fb;ydryl nee.gents, but 
that inhibition could be reversed with glutathione. Long and Mehler 
also showed that high concentrations of cyanide inhibit·,.\ the enzyme. 
Auricchio, et al. ,, (48) reported that vitamin K ca.u.se-s a decrease 
in .quinolinic acid formation. The oxidase activity was also 
depressed in leukemic rats (49) and rats fed 2-acetylaminofluore:ne 
( 50), a compound implicated as an antagonist of DPN. In the latter . 
two experiments activity could be restored with DPN. It has been 
suggested on this basis that DPN mey- be a cofactor as well .. 
Enzyme Specificity 
The work of Stanier"' et al. ( 51) regarding the mechanism 
of the oxidation of uomatic compounds led to the postulation that 
3, 4,,,,dihydro:xyanthranilic acid might be an intermediate in the 
oxidation of $)HA.A. Makino, ,et al., (52) reported that liver slices 
formed nicotinic acid when incubated for 24 hours with 3, 4,-,dibydroJCY-
anthranilic acid. Weinstock, et al. ( 5.3) and Hellman and Wiss ( 54) 
however., could observe no such conversion to either quinolinio or 
nicotinic acids by rat or hog liver preparations. It was not utilized 
by Xanthomonas pn.m.1 or by the rat for growth; no urinar, nicotinio 
or quinolinio acid was formed in the rat ( 5.3) • DI Angeli :c et al o , 
8 
( 55) found that antbranilic acid and the amide of 30HAA did not possess 
niacin-replacing· activity for the rat or serve as ,,,_ substrates for 
the JOHAA-oxidizing system of l iver. Gholson and Henderson (56) 
reported that 5-hydroxyanthranilic acid-l-Cl4 was not metabolized 
by the intact rat and was excreted in the urineo 
Purification of the Enzyme 
Purification of 30HAA oxidase has been attempted by several 
workers. Schweigert 1s group (10) fractionated an extract of acetone 
powders of liver and found that oxidase activity was in the fraction 
precipitated at a concentration of ammonium sulfate between 45 and 
65 per cent. Long et al. (11) and Mehler (33) attempted puri-
fication but found the preparations unstable to the conventional 
methods. Stevens and Henderson (47) obtained a 4-fold puri~ication 
by a heat step followed by the use of lead subacetate to remove 
inert proteins. 5.J.bsequent ammonium sulfate fractionation resulted 
in a loss of at least t wo-thirds of the activity. 
3 .. Prolduct of 30HAA Oxidation 
Mich work has been done to characterize the product of 
oxidation of 30HAA. The intermediate, referred to as Compound I, 
detected by its absorption maximum at 360 mµ (11, 12, 42), results from 
the oxidative fission of the benzene ring of 30HAA in the 3-4 position 
and has a half-life of about 40 mimtes at 25 ° C and pH 9o4 (30). The 
formation of compound I requires one mole of oxygen per mole of substrate 
(11), as already notedo The molar extinction coefficients have 
been reported as 28,300 (11) and 47,500 (57,58,59) at 360 mµ in 
different solventso Compound I is very unstable to heat but can be 
stored for several hours at -15 ° C in 80 per cent ethanol (11). Miyake 
et alo (42) and Long et al. (11) reported that the intermediate 
is unreactive to carbonyl reagents under natural conditionso They 
9 
reported, independently, that mineral acids caused a shift in the 
absorption maximum from 360 mµ to 315 mµ; after neutralization the 
maximum was found at 375 mµ instead of 360 mµ which suggested that a 
degradation had taken place to form a new compound. This degradation 
product, compound II, reacted with carbonyl re~gents, which indicated 
an oxidative deamination. 5lbs~quent work by Long (60) has shown that 
one mole of 8Jmllonia is released per mole of compound I when acid is 
added 0 Mehler (61) also observed that the isotope from carboxy1-c14 
30HAA was lost when compound I was converted to compound II. Wiss 
10 
et al. (62) reported that acid conditions cause decarboxylation of 
compound I, but it was not deam.inated, so that the condensation product 
was picolinic acid. Their suggestion that picolinic acid is therefore a 
non-enzymatic product of acid treatment has been criticized (63) in view of 
observations of others (33,35) who have noted its enzymatic formation. 
Wiss et alo (58) have reported the formation and properties 
of three derivatives of compound Io In their studies trichloro-
acetic acid at a final concentration of 5 per cent was used to 
precipitate the proteins. They reported the formation of a stable 
2,4-dinitrophenylhydrazone, a saturated aliphatic product 
formed by the catalytic reduction of compound I and a dinitrophenyl 
derivative of the reduced producto The infrared spectra of these 
derivatives indicated that the structure of compound I is that shown 
in Fig. 2. 
At present the structure of compound I is not known. 
The conditions f or the preparation of derivatives used by Wiss 
were such that compound I~ should ha..-e been formed. The structure 
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FIGURE 2 
META:OOLISM OF 30HAA; DEGRADATION OF COMroUND I IN VITRO 
11 
proposed, l-amino-4-formyl-l,3-butadiene-1,2-dicarbox:ylic acid (64), 
seems reasonable. There has been no evidence to support a two-step 
oxidation to give the products suggested by Miyake et al. (42) and 
Snell (65). The aldehyde and amino groups of compound I probably 
undergo a Schiff-base type condensation (66) with the loss of 
water to give quinolinic acid. 
4. Degradation of Compound I 
That compound I is spontaneously degraded to quinolinic acid 
(12, 17) has already been discussed. Nearly quantitative yields of 
quinolinate are obtained from rat liver preparations. The livers 
from bovine, guinea pig, pig (3.'.3) and other species (35) contain 
a cyanide-sensitive enzyme in the soluble fraction. Mehler (33) 
showed that this is a decarbo:xylase requiring no known cofactors 
and catalyzing the formation of picolinic acid from compound I. 
The formation of nicotinic acid has not been demonstrated in vitro, 
but the growth studies and urinary excretion of metabolites of 
niacin already mentioned support its formation in vivo. In the 
intact animal, however, the pyridinecarboxylic acids never account 
for more than 20 per cent of the degraded 30HAA (35) 0 Neither 
picolinic acid (34,35) nor nicotinic acid (34) is metabolized. 
When 0.02 mmoles per day of qui nolinic acid vas injected into 
r ats, 80 per cent was excreted unchanged (17). The dat a indicate 
that the major portion of 30HAA was metabolized via some other route. 
Acid was sho'Wll to degrade compound I to compound II, which is 
presumably l-hydro:xy-4-formyl-1, 3-butadiene-l-carbox:ylic aci d . 
This same compound appears to be produced as the first oxidation 
12 
product of catechol by an unidentified gram-negative organism (67). 
atch a route of degradation in ma:mnals has been suggested (68) tut 
has not been shown. 
Henderson and Hankes (69) reported that 25 per cent of 
the carbon-14 from tryptophan-Ja, 7, 7a-cl4 was expired as ol4o2 
in 12 hours. They al so showed (21) that 60 per cent of the isotQpe 
from carboxy1-cl4 l abeled 30HAA was expired in 3 hours. Gholson 
et al. (70) reported that 36 per cent of the isotope from tryptophan-
7a-cl4 was expired as cl4o2,and 40 to 50 per cent was present in 
the tissues 12 hours after the tryptophan was injected . The 
labeling pattern of isolated amino acids suggested that carbon-
7a of tryptophan is catabolized via the carboxyl of acetate. This 
obserTS.tion was confirmed when an acetate trapping technique with 
cyclohexyl alanine was used (71 ) . When 30HAA-1-c14 was injected into 
rats the isotope was found i n the methyl carbon of acetate (56). 
The interpretation of t hese dat a was that t he main route of 
tryptopban metabolism to CO2 i s via 30HAA, and that 30HAA is oxidized 
via compound I t o some aliphatic pr oduct, not through the pyridine-
carboxylic acids. 
Consideration of the possible metabolic sequences between 
JOHAA and CO2 suggest a number of carboxylic acids as intermediates. 
Gholson et al. (72,73) tested some of these by the metabolite over-
l oading technique in the r at with both tryptophan-7a-cl4 and tritiwn-
l abeled JOHAA . Glutaric acid was found to be l abeled in both cases. 
The carbon-14 f rom the tryptophan was found in the carboxyl carbon., 
again supporting the JOHAA-compound I pathway for tryptophan metabolism. 
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No other intermediates have been established. Figure 3 shows a 
hypothetical pathwey- for the formation of glutar.i.c acid from 30HAA 
(73). 
No conversion of 3()HAA to compounds other than picolinate 
and quinolinate has been demonstrated in vitro. In order for further 
metabolism to take place, 88 oxidation or dearnination must occur 
to prevent ring closure. 
Other Metabolic Paths of ,30HAA. Degradation. 
Though degradation of 3()HAA. to CO 2 via the 30HAA oxidase-
catalyzed reaction is moat probable, there is a second possibility. 
Viollier and Sullman (74) have reported the presence of an enzyme 
in the particulate matter of liver which metabolizes 30HAA to a 
red compound. This product has never been characterized. 
5. Conclusion 
The complete metabolism of 3()HAA to CO 2 is yet to be 
elucidated; indeed, the first step of oxidation has not been 
clearly defined. The oxi.dase has never been extensively purified, 
and this fact has made characterization of the product more difficult. 
The formation of niacin has yet to be demonstrated unequivocally in 
vitro. It is apparent that extensive studies in vitro a.re necessary 
to provide many of the answerso 
The purpose of the studies to be described was .3-fold: 
(1) to purify the enzyme and define the reaction in which JOHAA 
is oxidized to compound I, (2) to characterize the oxidation pro-
duct., and (3) to find a system to study the metabolism of compound 
I in vitro. 
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HYroTHEl'ICAL PATHWAY FOR THE :FDRMATION 
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GLUTARIC ACID FirlM 30HAA ( 67) • 
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II. METHODS AND MATERIALS 
A. Materials 
3-Hydroxyanthranilic acid (JOHAA) was obtained from 
Hoffman-La Roche. Reduced glutathione, cysteine-HCl, quinolinic 
acid and nicotinic acid were obtained from Nutritional Biochemicals 
Corp. Tris (2-amino-2-(hydroxymethyl)-1,3-Propanediol)' and sodium 
g-chloromercuribenzoate (pCMB) were purchased from Sigma. Picolinic 
acid, picrolonic acid, semicarbazide-HCl and thiosemicarbazide 
HCl were obtained from Eastman Kodak Co. All salts used in these 
studies were of C. P0 grade. Certain preparations of ~onium 
sulfate were recrystallized from 0.002 M Tris-0.003 M Versene buffer. 
Saturated am:monium sulfate at 3 ° C was prepared and adjusted to 
pH 8.0 with concentrated ammonium hydroxide. This salt solution 
was diluted one to ten for reading of pH. 
Tritium-labeled JOHAA was prepared by the method of 
Wilzbach (75) and recrystallized to constant specific activity 
(700 µc/mmole). Paper chromatography in Partridge solTent system 
(76) showed only one radioactive spot. 3-Hydroxyanthranilate-l-c14 
and the carboxyl-Cl4 labeled form were gifts from Dr. L. _V0 Hankes, 
Brookhayen National Laboratories. Le.ctobacillus plantarwn (formerly 
L, arabin~sus 17-5) (ATCC no. 8014) and all reagents for microbioassay 
were kindly supplied by Dr. R. J. Sirny, Oklahoma State University. Water 
used for enzyme purification was prepared by redistilling steam condensate, 
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passing it through a deionizing column and redistilling a third time in 
glass. This was found to be necessary because the deionized water 
contained some unidentified inhibitoro 
B. Preparation of Acetone Powders. Extra.eta and Homogenates 
Liver extracts were prepared from acetone powders. Rat 
livers were oQtained and used immediately in the early studies, but 
this species was not satisfactory later because of the large amounts 
of tissue needed in enzyme purification. Fresh beef liver was 
purchased for this purpose. 
Acetone powders were prepared by homogenizing the liver 
tissue with 10 volumes of cold acetone in a Waring blender for 2 
minutes at full speed. This mixture was then filtered with suction 
on a Buchner funnel and resuspended in three volumes of acetone. 
The Waring blender was used to aid in breaking the tissue pad. The 
preparation was again filtered under vacuum. The pad was broken 
up by rubbing between the hands in the cold and allowed to dry on 
large filter paper. After the powder was passed through a No. 40 
mesh screen to remove the fibrous material. it was dried over paraffin 
and P2 05 in vaouo. The product was stored at ... 15°c in vacuo until 
used. The extracts were prepared by add:i,.ng 9 volumes of glass-
distilled water to the powder and stirring. The mixture was allowed 
to stand one hour at room temperature and centrifuged at 2QC and 
10,000 xg for ten minutes. 
Homogenates were prepared for purification studies in a 
one to five w/v ratio of fresh tissue to water. Homogenization 
was accomplished at 5°c in a Wfring blender for one minute at 
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full speed. The suspension was passed through two layers of cheese 
cloth to remove large unbrocen particles. Homogenates used in 
studies on the degradation of compound I were prepared in a similar 
manner except that a Fotter-Elvehjem homogenizer was used. 
c. Quantitative Methods. 
1. En;yme Assays 
Specific methods for assays of the enzyinic reactions are 
described in the individual sections. 
2. Protein Determination 
Protein was determined by the trichloroacetic acid-turbidity 
method with the procedure of Stadtman~ et al. ( 77) and by 280 m µ 
absorption (78). 
3. Microbiological Assay for Quinolinic and Nicotinic Acids 
Quinolinic acid was asaa;yed as nicotinic acid. The quinolinate 
was chemically decarboxylated by autoclaving with glacial acetic 
acid. A microbiological assay was done by the modified method of 
Snell and Wright (79) using Lactobacillus plant~. Growth was 
measured by titrating the acid produced ai'ter a 72-hour incubation 
at 37°c. 
4. I@otopic Analyses 
Paper chromatograms of radioactive materials were analyzed 
by a Radiological Service Co. Automatic Windowless Chromatogram 
Scanner. Quantitative assays for the isolated quinolinic, picolinic 
and nicotinic acids were made by the isotope dilution technique (35). 
Tritium-labeled compounds were decomposed by the zinc fusion method 
(80), and carbon-14 labeled compounds were degraded by the wet 
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combustion method of Van Slyke (81). Radioactivity was measured 
with the Cary model 31 vibrating reed electrometer. The Packard 
Tricarb liquid scintillation counter was used for analysis of 
isolated glutaric acid. Five-tenths mlo aliquots of the eluted 
fractions from the silica gel column were added to 10 mlo of 
scintillation fluid1 (82) and the preparations were counted for 
5 minutes. 
1 EIJ % toluene, 40% absolute ethanol., 0.4% diphenyloxazole 
and 0.02% roroP. 
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III. EXPERIMENTAL AND RESULTS 
A, 3-Hydro:xyanthranilic Acid O::ir.J.d,ase 
Purification of )JHA.A oxidase was undertaken to obtain 
information concerning the properties of the en~yme and the product 
of the reaction it catalyzes. Stevens and Henderson (!,..?) obtained a 
,4.-fold purification of the oxidase by a heat step, a pH step and treat= 
ment with lead subacetate. When attempts were made to fractionate the 
enzyme with ammonium sulfate it was found that a substantial amount of 
activity was lost. 
The data reported in paragraphs 1 to 5 were obtained by Dr. 
F, R. Leach and were confirmed by the author. 
1. Effect o:f....Arr@.9.niurn Sulfate on Activity 
The loss in activity when salt fractionation was attempted 
suggested that the ammonium sulfate was inhibiting or denaturing the 
enzyme. 11.n experiment was designed to test the effect of the salt on 
enzyme activity. All enzyme assays were rnade by spectrophotometric 
measurement of the rate of formation of compound I at 36o mµ,. Reactions 
were incubated in cuvettes with a one cm light path. A control consisted 
of all components before the addition of substrate. Optical density 
readings were taken at 15-second intervals for 2 minutes on the Beckmari 
model D. U. spectrophotometer. 'rhe reaction mixtures contained O, 3 µmole 
of ferrous sulfate and 0.1 ml of a 20 per cent heated and centrifuged 
preparation of enzyme. Saturated armnonium sulfate ( 0 .1 ml) was added 
at the same ti1ne as substrate (cu:r-ve 1, Fig. 4) :1 2 minutes after sub-
strate (curve 2) and 2 minutes before substrate (cm'Ve 3). It was 
20 
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THE EF:F'EC'.I' OF AMMONIUM SULFATE ON 30HAA OXIDASE ACTIVITY 
observed that the salt had no effect on the absorption ma.xi.mum. or 
extinction coefficient of compound I when added af'ter the reaction 
had proceeded 2 minutes. The ad.di tion of the salt . with substrate 
caused only a slight decrease in activity but not enough to account 
for the loss 111 activity found during purification.. When the 
enzyme, f e r::-rous ion and ammonium sulfate were preinm.:i.birl;ed 2 minutes 
before addition of substrate., there was an activation rather t.hari 
inlii bi tion. 
2. Effect of Time on the Agtivation by .Ammonium Sulfate and 
Ferrous Ions. 
Preincubation time required for activation of the heated 
enzyme by ferrous sulfate and ammonium sulfate was dete:rniined. As 
is sho"m in Fig. 5 maximum activity was attained after 5-minute-; 
exposu:r)e of the enzyme to these components. This study was 
repeated after the concentration of ammonium sulfate for best 
activity was deter.mined and after the enzyn:e was purified. ;;n 
identical. curve was obtained. 
J. Concen!,ration of Ammonium Sulfate for M~tilnUJU Act.ui1/x. 
The effect of changing the amount of ammonium sulfate on 
the reaction rate d:uring the 5-minute preincubatio.n is shown in Fig. 6. 
Maximum activation occurs when the solution is appro:JO.mately 0.035 
molar with respect to this sal.t. At higher conce.ntrations there 
is a decrease in the activity. This value is not absolute and 
yaries somewhat with the particular preparation, the stage of' 
purification and the age of the preparation. In two cas~s it was 
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OONCENmATION OF .AMt()Nlm( SULFATE FOR MAXIMUM ACTIV' ATION 
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4. Effect of other Ions. 
Other salts were tested to determine the specificity of 
this activation on the preparation. It was found that other salts 
having neither ammonium. or sulfate in common gave this activation 
as well. Further, Triton--&-100, a non-ionic detergent caused 
stimulation at this state of' purification. Thus it ml!zy' be con ... 
sidered that activation is the result of the ionic effect of the 
salt solutions and to the surfaotive properties of the detergento 
It should be noted, however, (Table I) that the ionic strength 
fpr maximum activation with each salt was different. Also, 
Triton...1~100 failed to activate in more pure preparations. 
5. Sequence of Addition of Ferrous Sulfate and Ammonium. 
Sulfate. 
Strehler and Comier (8.3) in a study of bacterial luminescence 
used a method for the determination of the order of interaction of 
various factors in multicomponent systems. This suggested. a uimilar 
study for the determination of the activation sequence of the oxidase. 
This consisted of comparing the enzymatic activities resulting when 
each component is added last to the preinoubation mixtur·e containing 
the other components. If the component that reacts first with the 
enzyme is added first, activation of the en2zy1ne should begin bsd'ore 
the addition of the other component. This fact will then be reflected 
in an increase in the enzymatic activity when substrate ia added. 
Conversely, if t~ component that reacts last is added first, no 
activation will occur until the first component is added, and there 
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1 
EFFECT OF SEQUENCE OF ADDITION OF AMMONIUM SULFATE 
.AND FERRDUS SULFATE ON ACTIVITY 
27 
2 
When ammonium sulfate was added 3 minutes after ferrous ion there 
was the least amount of activity (curve 1). When ammonium sulfate 
and ferrous ions were incubated together for 3 minutes and the 
enzyme added for two minutes there was only a slight increase in-
dicating that the two salts did not interact to produce a required 
intermediate in the absence of the enzyme (curve 2). When the 
enzyme was preincubated with ferrous ion there was no increase 
in rate above curves 1 and 2 showing a requirement for ammonium 
sulfate (curve 3). Enzyme preincubated 3 minutes with ammonium 
sulfate before addition of ferrous sulfate· showed a slight in-
crease in activity over the others. This suggested that the primary 
activation was an ion effect before addition of ferrous ions. 
Though this difference is small several experiments have given the 
same result. Curve 5 shows an incubation with both components 
added to the enzyme 5 minutes before substrate. 
6. Activation Studies 
In the course of purification other factors in addition 
to glutathione, ferrous ion and ammonium sulfate have been observed 
to produce remarkable activation or restoration of activity. Figure 
8 show$ the effect of acid on the activity and specific activity 
of the enzyme. An homogenate was centrifuged at 105,000 xg for 
30 minutes, heated to 5_5°C for 5 minutes., cooled and recentrifuged. 
Concentrated hydrochloric acid was added slowly with rapid stirring 
to the enzyme until the solution was pH 3. 5. The resulting preparation 
was allowed to stand at room temperature for the period of study. 
Five-ml aliquots were removed and neutralized at suitable ti.me 
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EFFECT OF ACID-EXroSURE TIME ON SPECIFIC ACTIVITY 
JO 
estimated by measurement at 280 mµ (78). It was found that i.TJJinediately 
after the addition of acid there was a 2-fold increase in activity. 
The specific activity reached maximum values after 10 minutes. 
Longer exposure to the acid resulted in a rapid decrease in enz;yme 
activity. This pH adjustment step was incorporated into the pu.rification 
sequence to be described • 
.Alkaline conditions were also found to give a stimulation of 
enzyme activity equal to or greater that"l that observed by acid 
treatment. There was a restoration of activity when the ammonium 
sulfate-precipitated enzyme that had lost its activity was exposed 
to alkaline pHs. Enzyme purified through the calcium phosphate gel 
stage (described below) was used in a study to determine the optimum 
conditions for alkaline activation. Five ml samples were adjusted 
to the desired pH with 0.1 and 1.0 N sodium hydroxide. The aliquots 
were then refrigerated for 5 hours and assayed at pH 7.0. Figure 9 
shows that maximum activation over this time period occu.rred at pH 
10.0, A pH of 6.0 caused a. complete loss of activity during this time. 
It was noted that though there was a large stimulation at alkaline 
pH the enzyme was no more stable than at pH 7.0. 
7. Stabili tx_ Stua.,_ie.§ 
It was obvious from the activation studies that stability 
of this en7,yme and activation were not necessarily related. Both 
acidic and basic conditions stimulated enzyme activity, but nei t,her 
was suitable for maintaining this activity. A series of conditions 
for storage of the enzyme was tested. A sample of the calcium 



















EFFECT OF AJ.KALINE pH ON ACTIVITY 
11 12 
. TABLE II 
STORAGE CCNDITIONS FOR AMMJNIUM SULFATE-
PRECIPITATED ENXYME 
Time, Activity, Per cent of' 
Treatment hours unitsLml control 
Control, refrigerated .0 718 100 
Control, refrigerated 24 424 59 
Control, refrigerated 96 92 13 
Nz, cysteine., refrigerated 24 t£>2 85 
N z' cysteine, refrigerated 96 556 78 
Frozen 12 820 114 
Frozen 96 738 103 
Lyophilized, frozen 72 646 ~ 
Lyophilized, refrigerated 72 408 57 
32 
These were stored as shown in Table II for various lengths of tL~e 
and were assayed. The enzyme that was- frozen had the best retention 
of activity. Cysteine caused a good retention of activ1.ty, but 
glutathione would stabilize somewhat better. In subsequent studies 
storage of an ammonium sulfate-fractionated enzyme by freezing and 
with 10-3 M glutathione for two months not only gave :retention of 
activity but caused nearly 2=fold increaseQ 
8. Purification Sequence 
Several workers (11,33,42) reported the oxidase to be 
unstable to conventional purification techniques, but in view of 
the results of the activation and stability studies further puri= 
fication was made possible. All enzyme purification steps were per-
formed at 3-5 C0 unless otherwise specified. Fractions were assayed for 
enzymatic activity spectrophotometrically. Ass~ systems contained 
0.3 µmole ferrous sulfate, 3. µmole of glutathione, 10514mole of 
ammonium sulfate and eneyme in 0.01 M Tris buffer, pH 7.0, 11'\ 3~0 
ml upon addition of 0.1 µmole of' JOH.A.A. An enzyme concentration to 
produce an optical density change of 0.400 in two minutes was most 
desirable; ~ubstrate concentration does not become limiting during 
this period, and experimental error in making readings is minimized. 
One u..r1i t i~ that amount of enzyme producing an optical density change 
of 0.010 per minute under the conditions of the assay described 
above. 
The 20 per cent homogenate was centrifuged in the Spinco 
preparative centrifuge at 105,000 xg (30 rotor) for .30 minutes, 
and the precipitate was discarded. The supernatant was heated 
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in stainless steel beakers with constant stirring for 5 minutes at 
55°c. The heated fractions were ccoled immediately"'tm.d centrifuged 
at 25,000 xg for 30 minutes in a Lourdes "Superspeed" refrigerated 
centrifuge to remove denatured protein. The supernatant was acidified 
to pH 3.5--307 with 2 N bydrocblcric acid and allowed to stand at 
room temperature for 10 minutes before neutralization with 4 N sodium 
:hydroxide. The preparation was again cooled to 3°c and centrifuged 
at 25,000 xg. It is notable that treatment by acid brought the 
total ·activity to a relatively constant value in most preparations. 
The supernatant solution was treated with 10 ml calcium 
pho_sphate gel (84) (25.8 mg per ml.) per 100 ml of enzyme solution 
at 5°c for 25 minutes with continued stirring. The mixture was 
centrifuged for 20 minutes at al,000 xg, and the gel residue was 
discar1ed. The enzyme solution was then fractionated with cold 
saturated ammonium sulfate at or above pH 7. 0. The bulk of the 
enzyme is precipitated between 45 and 65 per cent saturation, 
(Fig. 10) but the fraction between 50 and(;{) per cent was taken to 
eliminate as much inert protein as possibleo The precipitate was 
dissolved in 0.1 the original volume of 0.01 M 'l'ris buffer, pH 7.0 
to give a solution containing 6 to 8 mg of protein per mlo _This 
stage of purification has been the one of highest specific activity 
and has been stored frozen with 10-s M glutathione for two months 
with no loss in activity. The average specific activity was 
11,000 following the steps described above with certain preparations 
as high as 21 9 000. The extent of purification was somewhat variable 
since the specific activities of the homogenates differed from one 
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Further purLfication has not been successful because of 
the instability of the enzyme to dialysis required to remove excess 
ammonium sulfate.. The use of DEAE cellulose columns in further 
purification has been attempted. The dissolved ammonium sulfate 
fraction of enzyme was placed on a column 2 x 34 cm and eluted with 
water. Two ml fractions were collected and assBJ'ed. It was found 
that most of the protein was eluted in the first 16 ml and that 
activity corresponded with this protein peak, (Fig. 11). It is 
probable that this does not mean the enzyme is pure but, rather, 
that the ammonium sulfate existing in solution caused stripping 
of the colurnn. When the enzyrne preparation was dialyzed for 3 hours 
before column treatment all protein stayed on the column and was 
eluted with 0.1 M phosphate buffer, pH 7.1. However, two-thirds 
of the activity was lost by the dialysis and column treatment and 
could not be restored. Numerous dialysis studies have been undertaken 
with the ammonium sulfate fraction of enzyme, but no suitable 
conditions have yet been found which can be ·used to remove the salts 
without losing activity. In addition to those steps desoribed 11 
negative adsorption on Nor Lte A (3g per 100 ml of enzyme) for 25 
minutes was used in earlier purification, but subsequent use of 
this step was no longer successful in increasing specific activity. 
The reason for this is not known. Variation of pH du.ring adsorption 
had no effect on the ability of the charcoal to remove foreign proteins. 
A summary of a typical purification is shown in Table III. 
9. M§asure of Purity 
Starch Gel Electro2hor3sis 















'g •n § 






3 4 5 6 7 8 
Fraction number 
FIGURE 11 
ELUTION OF PURIFIED ENZY'ME FRACTION F:OOM DEAE CEU..ULOSE 
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TABLE III 
PURIFICATION SEQUENCE OF 30HAA OXIDASE 
Vol., Activity, Protein., Sp. Act., Degree of 
ml un;i.tsiml Total Units mg/ml units/mg Purification Yield 
nogenate 870 1,220 l0.6xl05 70 17.4 1 100 
:,ernata.nt (:OQ 2,0(:0 12.4 15 137.0 7.9 117 
3.ted 5l0 3,520 18.0 8.5 414 23.8 169 
Ld-Treated 400 12,240 49.0 4.3 2,850 163. 5 462 
L-Treated 420 10,000 42.0 2.5 4,000 230 · 396 
I4 ) 2S0 100 96,000 96.o 2.7 35., 555 2,040 g:)7 
1cipitited 
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the starch gel method of Smithies (85) to deter.mine the approximate 
per cent purity of the a.nnnonium sulfate fraction. Potato starch 
gel (7 per cent w/v) was prepared in 0.03 M Tris buffer, pH 8.5. 
Blocks were prepared by pouring the hot gel into trays, 1 x 4 x 36 cm. 
Two-tenths ml of enzyme (one per cent solution) was absorbed on a 
strip of filter paper and inserted into a slit in the gel. Electro-
phoresis was conducted for 14 hours at 3° C in 0,03 M Tris at 125 volts. 
The gel was removed from the tray and cut into 4 sections lengthwise. 
Two sections of the gel were stained with saturated Amide Black 10-B 
protein dye in methanol: water: glacial acetic acid (50:50:10 v/v). 
3-Hydro:xyantbranilic acid was applied to one of the unstained sections 
to determine the location of the oxidase. The experimental procedure 
was as follows: Whatman no. 1 paper pretreated in a solution of 
0,1 mM ferrous sulfate, 1.0 rnM glutathione and 0.035 M ammonium 
sulfate was applied to the gel. The strip was removed after 5 minutes 
and a second strip of Whatman no. 1 paper, treated with 1.0 mM 30HAA 
and partially dried, was applied. After 30 minutes the paper was 
removed. The distribution of 30HAA in the gel was examined with an 
ultraviolet Mineralite (long wavelength). Fluorescence of the 
30HAA transferred from the paper to the starch gel was observed except 
at one spot which corresponded to the protein band detected by the 
dye. It appeared that this area contained active oxidase which 
metabolized the substrate. Attempts to elute the orldase from the 
remaining gel strip by freezing and thawing and by extraction with 
ammonium sulfate and 0.1 M phosphate buffer were unsuccess~ul. 
The use of this method as a purification step was not prom:i.sing. 
Amido Black dye treatment showed that there were at l east 
four protein components. These components did not move more than 
5 cm from the origin during the 14-hour period suggesting that the 
isoelectric point m~ be near pH 8.5. From the size of the individual 
protein components it was estimated that the enzyme could not be 
more than 25 per cent pure at this stage of purification. 
Ultracentrifugation 
A sampl e of the purified enzyme was examined i n t he 
ultracentrifuge at the University of Illinois. The enzyme fraction 
was prepared for ultracentrifugation by dialysis for one hour at 
pH 7. 5 against O. 02 M sodium phosphate. The time-sequence photo-
graphs taken during ultracentrifugation showed a broad protein band. 
A dark residue settled to the bottom. It cannot be determined whether 
these results are characteristic of the native or denatured protein 
since the effect of dialysis i a not known {Fig. 12). 
10. Enzyme Properties 
Km values of the enzyme for JOHA.A were determined in four 
experiments with different preparations of the ammonium sulfate-
fracti onated enzyme. All results compared ;favorably, and the average 
value was 2.08 x 10-' (Fig 13). At higher concentrations (Fig. 14) 
it was observed that the substrate did not inhibit as was previously 
reported with crude preparations (46). 
The ferrous ion concentration required for maximum activation 
differed slightly from that reported by Stevens (47). An 11apI,a .'."ent 11 
Km for ferrous ion was found to be 2.0 x 10-!>. An i ncrease in 
enzyme activity was observed with an increase of ferrous ion greater 
40 
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than 10-4 M but this activity was not on the linear portion of the 
curve obtained with more dilute solutions (Fig. 15). 
11. Possible Function of the Sulfh.ydryl Group on the Enz,yroe. 
The sulfbydryl group is necessary for activity of the 
enzyme. The question to be answered is, does this functional group 
participate directly in catalysis or is it involved in maintaining 
the structure of the enzyme. Suda and Tokuyarna (86) have used a 
method to suggest the function of the sulfhydryl group in the two 
enzymes, homogentisicase and pynoc~techase. This involved the 
sequential addition of R - choromerJuribenzoate (~MB) and substrate 
to the enzyme. A similar procedure was followed with 30HAA oxi.dase. 
The results of the experiment are sho'Wn in Fig. 17. The enzyme 
was preincubated in the usual manner but without glutathione. The 
two compounds, pCMB and 30HAA,were added in sequence 15 seconds apart. 
When 30HAA was added first or at the same t~ne as pCMB, there was 
25 per cent inhibition, but when pCMB was added first there was 
68 per cent decrease in activity. This could be explained if the 
sulfhdryl group is at or near the active site of the enzyme. The 
pCMB and 30HAA compete for this position. 
12. Picolinic Acid Carboxvlase in Beef Liver 
During the purification of the oxi.dase from beef liver 
it was often observed that the 3€:D rnµ maximu~ would decrease more 
rapidly than a non-enzymatic control. This phenomenon was noted 
in all purification steps but was particularly observed in the latter 
stages (ie. pH and gel treatment, 4D-65 per cent ammonium sulfate 
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EFFECT OF TIME OF pCMB mEATMENT ON ENZY"ME ACTIVITY 
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FIGURE 17 
EFFECT OF ADDITION OF .30HAA AND pCMB IN SEQUENCE 
ammonium sulfate caused inhibition of the disappearance of compound I. 
When the enzyrnatic oxidation of 2 µmole of .30HAA was observed in 
the Warburg respn-ometer it was found that considerable gas was 
given off that slowly disappeared. If the gas were CO it was 
' :2 
probably being absorbed by the potas 3ium hy:lroxide in the center 
well. A radioisotopic tracer study with tritium-labeled JOHAA was 
done to determine the nature of the products. The substrate was 
treated with an excess of the enzyme preparation to give compound I. 
When the absorption at JEo mµ,reached a maximum, the reaction was 
accurately divided into two equal. portions. To the first portion 
was added four volumes of cold absolute ethanol. The reaction in 
the second portion was allowed to continue 15 minutes at which time 
all of the compound I had disappeared. Four volumes of ethanol 
were added to this 'portion. The two preparations were centrifuged 
15 minutes at 20,000 xg to remove the protein, and 100 mg of 
quinolinic acid and 100 mg af picolinic acid were added. The 
samples were concentrated nearly to dryness on ar)tary evaporator, 
then diluted to 10 ml and placed on Dowex 50-(H)- W x 8 columns 
2 x 35 cm. 
The two acids were eluted from the columns with O.lNiH Cl 
in 10 ml ~liquots. The quinolinic acid, found in fractions 4 to 8, 
was recrystallized twice from 50 per cent ethanol; the picolinic acid 
in fractions 38 to 50 was sublimed twice at 10 5 C(J in Y !'icu S*-
Melting points were the same as the authentic acids. Samples were 
weighed, combusted and counted on the vibrating reed electrometer. 
Table IV SU1llIIlarizes the results. The major product of the enzymatic 






DETERMINATION OF THE AMOUNT OF QUINOLINIC AND 
PICOLINIC ACIDS PRODUCED BY BEEF LIVER 
Control Test 
incubated 2 min. incubated 15 min. 
ill!JtC per cent mµc per cent 
138 57 37 1306 
104 43 235 86.4 
242"'' 272 
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purification of the oxidase was picolinic carboxylase. It is interesting 
that such rigo.rous treatment as acid, heat and calc;i,um phosphate gel 
did not resolve these two closely ,related enzymes. The enzymes 
could be separated by careful ammonium sulfate fractionation. The 
50 to (:f) per cent salt fraction was essentially free of picolinate 
carboxylase activity. 
. . 
B. Studies on The Structure of Compound I 
The structure of the enzymatic oxidation product of 30HAA, 
compound I, has not been conclusively established. Wiss and Bettendorf 
(58) have reported the only isolation of derivatives of compound I, but 
the conditions for removal of proteins in their work were such that 
compound I might have been converted to compound II, a product 
shown to react with carbonyl reagents (11). Wiss later reported 
that acid conditions convert compound I to picolinic acid (62). 
The experiments to be described were done to determine whether the 
methods used by Wiss would, in fact, destroy compound I or convert 
it to picolinic acid, and to prepare stable derivatives of this 
intermediate. 
1. Method of Assay 
The enzymatic reaction for the formation of compound I was 
routinely fol lowed by measuring the rate of disappearance of f1.uorescence 
of JOHAA. Reaction mixtures for the oxidation of 2 - 3 µmoles of 
30HAA contained 0.3 J.l)llOle ferrous sulfate and O. 5 ml of a 10 per cent 
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rat liver acetone powder extract in Krebs-Ringer phosphate buffer, pH 7.0. 
The volume was adjusted so that addition of substrate resulted in a 
total volume of 3.0 ml. One-tenth ml aliquots were removed at various 
time intervals and transferr-m to 9.9 ml of absolute ethanol. Fluorescence 
was measured in the Coleman Photofluorometer with B-1 and PC-1 filters 
against a standard of quinine sulfate. A unit of oxidase activity 
was defined as the amount of enzyme necessary to oxidize 1 µmole of 
30HAA per minute. 
2. Effect of Trichloroacetic Acid on Compound_! 
a. Measurement of Qµinolinic and Picolinic acids 
Twenty- t hree µc (8 µmoles) of tritium-labeled 30HAA was 
oxidized to compound I, and the preparation was immediately divided 
into two fractions. Four volumes of cold absolute ethanol were 
added to one portion; the other was cooled to 3°C and 3 ml of 50 
per cent trichloroacetic acid (TCA) added. The denatured proteins_ 
were removed from both by centrifuging at 9,000 xg for 3 minutes at 
0°C. The TCA-treated preparation (5 per cent) was neutralized after 
both solutions had been allowed to stand at 0°C for 1 hour. Both 
reactions were warmed to 50°C to allow complete conversion to the 
pyridine carboxylic acids. One hundred mg. of carrier picolinic 
and quinolinic acids were added, both solutions were reduced in volume, 
and after adsorption on Dowex-50-H 1.5 x 30 cm, the colurr,ns were 
developed with O.l N !Cl (35). The two acids were identified by 
the ferrous ammonium sulfate spot test (87). The quinolinic acid 
from the ethanol-treated reaction was eluted in the fractions between 
40 to 80 ml. Probably because of the high salt content the acids in 
the TCA-treated mixture passed through the column with no separation. 
Rechromatograpey of the acids on a larger column (1. 5 x 48 cm) and 
el ution of quinolinic acid with water resolved the mixture. The 
quinolinate was found in the fractions collected between 10 and 30 
ml , and the picolinic acid was eluted by l(j) to 211) ml of O.l N HCl. 
Quinolinic acid was recrystallized from 50 per cent ethanol, and the 
picolinic acid was sublimed at l00°c in vacuo. Samples were weighed, 
combusted and counted on the vibrating reed electrometer. The results 
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contained in Table V show that picolinic acid is not a product of TCA 
treatment of compound I, contrary to the report of Wiss (62). It is 
also evident that compound I must have been destroyed, since its 
condensation product, quinolinic acid, is found to account for only 
7 per cent of the total isotope under these conditions. It was 
concluded that TCA was not satisfactory for removal of proteins from 
preparations of compound I. 
be Structure of Compound II 
Long et al.. (11) and Miyake et al., (42) reported that 
compound I is unstable to mineral acids and is converted to a 
second product, compound II, with the loss of ammoniao Compound II 
was probably the major product in the experiment described above. 
An experiment designed to determine whether compound I loses the 
)C-carboxyl group as well as the amino group when treated with acid, 
was done 0 3-Hydroxyanthranilic acid-l-cl4 and -carboxyl-C14 
were used as substrates. This experiment was done in view of the 
unpublished.results of Benassi and Henderson that the carbozyl-
labeled compound I loses its radioactivity when treated with carbonyl 
reagents in acid solution. J-Hydroxyanthranilic acid containing 49 
:mp.c of carbon-14 in each of the_ two positions was oxidized to 
compound I with an acetone powder extract of liver, and each reaction 
mixture was divided into two equal portions. One portion was 
treated with 2 N HCl to pH 1.0. Water was added to the other. 
After 5 minutes the acidified portions were neutralized, and all 
mixtures were treated with four volumes of ethanol .. Aliquots were 




EFFECT OF 5 PER CENT TRICHLOROACEI'IC ACID ON COMPOUND I 
Treatment Tritium in: QA PA Total 
2er cent 2er cent ~r cent 
Ethanol, pH 7 54.0 3.4 59~0 
TCA, pH 1 7.0 3.7 10.7 
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The remainders were dried in vacuo, combusted and counted. The results 
in Table VI show that acid treatment of carbo:xyl-labeled compound I 
caused a loss of 75 per cent of the radioactivity. Isotope from 
ring-labeled compound I was quantitatively recovered. It is apparent 
that compound I is decarbo:xylated as well as deaminated in its 
conversion to compound II. Recovery of the isotope from compound II formed 
from 30HAA-l-C 14 rules out the formation of a volatile product. A 
recent report by Mehler (t:O) has verified this observation. 
3. Preparation of Derivatives of Compound I. 
a. Catalytic Reduction of Compound I 
In view of the fact that TCA destroys compound I, the 
method of preparation of derivatives by catalytic reduction attempted 
by Wiss (58) was repeated using cold ethanol to precipitate proteins 
and stop the enzymatic reactions. Seventy ml,lc of 30HAA-l-C 14 was 
oxidized to compound I as described in section B-,.l, Four volumes 
of cold ethanol were added, and the mixture was centrifuge:'lat 10,000 
xg for 5 minutes at -15°C. A portion was allowed to stand at room 
temperature such that quinolinic acid-3-C 14 was formed. The re-
maining supernatant was immediately reduced at 0°C under 3 atmospheres 
of hydrogen pressure with Pt O as catalyst. Reduction of the · 
2 
quinolinic acid -3-C14 under the same conditions as well as quinolinat~ 
HC1-3-C14 in absolute ethanol was also done. The three resulting 
preparations were drie~ in vacuo and chromatographed on Whatman 
no. 1 paper using two different solvents, butanol:pyridine:water 
(6:4:3, v/v) and the Partridge system (76) butanol:glacial acetic 
acid:water, (5:1:4, v/v). Radioactivity was detected by the windowless 
chromatogram scanner. Results of the experiment are contained in 
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TABLE VI 
EFFECT OF ACID ON THE CARBOXYL GROUP OF COMPOUND I 
0 1 D1 of Aliguots Radioactivi t;y: Per c~nt Total 
30HAA-l-C 14 360 mµ 375 mµ d/s in Acid 
Before acid .505 .097 574 
After acid ,380 .421 573 100 
30HAA-C 1400H 
Before acid .485 .095 596 
After acid .298 .325 151 25.3 
TABLE VII 
CHROMATOGRAMS OF REDUCED COMPOUND I, QUINOLINIC 
ACID AND QUINOLINIG ACID HYDROCHLORIDE 
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______________ ,_I}utanol: pyridine :water Butanol: acetic acid:water 
Quinolinic acid-3-C14 Ool 0.1 
Reduced compound I-3-C14 






Table VII. Quinolinic acid in both systems has an Rf of 0.1. Under 
the conditions used for the reduction of compound I, quinolinic acid 
was not reduced. The r eduction of compound I in 80 per cent ethanol 
at pH 7.0 pro~ced one compound with an Rf the SB.Ile as that obtained 
when quinolinic acid-J-Cl4 was reduced as the hydrochloride. Since 
it has been reported that catalytic reduction of quinolinic acid-
-HG+ resulted in the foI'll.ation of~ and~ 2,3-piperidinedicarbo:xylic 
acid (88) these results suggested that compound I was reduced to 
this compound under neutral conditions (Fig. 18). 
To verify this possibility an isotope dilution study was made. 
2,3-Piperidinedicarbo:xylic acid was prepared as follows: 2.0 g of 
quinolinic acid was diseolTed in 175 ml absolute ethanol and the solution 
saturated with dry hydrogen chloride gas. This was reduced under 50 
pounds pressure of hydrogen gas using 0.5 g Ft02 at 3° C for .14 hours. 
The product was filtered, taken to dryness on the rotary evaporator 
and kept in~ over NaOH pellets and P205 overnight. The dried 
yellow residue was dissolved in 25 ml of hot acetone-water (lil). 
Darco G-60 was added, and the solution was heated 3 mizru.tes and filtered. 
The .volume was readjusted to 25 ml ,by adding water , and then acetone 
was added until the volume was 50 ml . vJhite needle-like crystals 
formed on standing overnight at 3° C. The product was recrystallized 
from acetone-water and melted at ~39° c, leaving no resi due. The pH 
was adjusted to 3.5 and the recrystalli zed compound melted at 227° c. 
No gas formation due to carbon dioxide was observed near 180° C. This 
indicated that no quinolinic acid was present. These melting points 
(239° and 227° C) are in agreement with those of the cis i somer of 
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indicates no reaction 
PIDDUCTS OF BEDUCT+ON OF COMFOUND I 
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piperidine dicarboxylic acid and its eydrochloride, respectively (88). 
One~ hundred· ,ninety m µc of JOHAA-1-C 14 was oxidized to 
compound I, and the mixture was treated with ethanol as before; 
two-thirds of this was allowed to condense to quinolinic acid, and 
one-third was reduced under 3 atmospheres of hydrogen with PtO for 
2 
12 hours at 0°C and pH 7.0. The quinolinic acid -J-c14 was divided 
into two parts. One portion was reduced catalytically in anhydrous 
ethanol and hydrogen chloride. An aliquot from each of the three 
preparations was removed for microbioassay to determine quinolinic 
acid. One hundred mg of carrier cis piperidine dicarboxylic acid 
was added to these solutions and the diluted product recrystallized. 
Samples were weighed, combusted and counted. The results in Table 
VIII show that 30 per cent of the reduced quinolinic acid-3-G14 was 
cis piperidine dicarboxylic acid. None of the quinolinic acid-3-·C 14 
was recrystallized upon the addition of unlabeled piperidine dicarboxylic 
acid. Twenty-one per cent of compound I was reduced to form a product 
which gave cis piperidine dicarboxylic acid. Microbioassay indicat ed 
that 50 per cent of the compound I had been converted to quinolinic 
acid before i t was reduced. If half of the material converted to 
piperidine dicarboxylic acid were in the trans form and were not 
isolated, this would mean that over 80 per cent of the cis isomer 
was recovered. By this same reasoning €JJ per cent of the quinolinic 
acid HCl-3-C 14 may have been reduced to the cis isomer. A sample 
(100 µ. g) of isolated piperidine dicarboxylic acid-C 14 chromatographed 
on paper with butanol: pyridine; water, (6:4:3, v/v) had a small but 
well defined spot at Rf of 0.82 conf:inning the fact that the major 
TABLE VIII 
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80% EtOH, pH 7.0 
21.3 
80% EtOH, pH 7.0 
radioactive spots obtained in previous chromatograms were cis 
2,3-piperidinedicarboxylic acid. 
To determine whether an aliphatic amino dicarboxylic acid 
was also formed upon reduction of co pound I, 2,4-dinitrofluorobenzene 
(DNFB) was added to a reduced mixture of the intermediate. This 
reagent was also added to quinolinic and 2,3-piperidinedicarboxylic 
acids as controls. Approximately 27 lllflC of reduced compound I and 
quinolinic acid and 2.0 llig of the crystallized piperidinedicarboxylic 
acid was made basic with sodium carbonate (pH 8.0) and treated with 
5 ml of ethanolic DNFB (0.1 per cent w/v). The reaction mixtures 
were shaken two hours and taken to dryness in vacuo. The residues 
were washed five times with 5 ml of ether, and the flasks were ex-
tract ed with 1 0 0 ml of ethyl acetate and 1.0 m. of water to remove 
any DNFB derivatives. The ethyl acetate and water extracts were 
dried, redissolved in 2 or 3 drops of ethyl acetate, combined and 
placed on a paper chromatogram. The solvent used was butanol: 
NH3 (1:1, Y/v). The ammonia was a 1 per cent aqueous solution. 
The resu.lts in Table IX show that none of the radioactivity coincided 
with the yellow spots of the dinitrophenyl (DNP) derivatives. These 
results imply that there were no aliphatic products formed by reduction 
of compound I. It is apparent that the reagent did react with several 
compounds, probably amino acids, in the extract. This indicates that the 
experimental conditions were suitable for reaction of the reagent with 
amino compounds. The Rf for radioactivity from 2,3-piperidinedicarboxylic 
acid and reduced compound I again coincided at 0.92. 




DINITBDPHENYL DERIVATIVES OF THE PRODUCTS OF REDUCTION 
Reactants 
DNFB + QA-3-C 14 




Rf Values (Butanol :NH3 
C 14 DNP Derivatives LYellow Spot) 
0.1 0.56 
0.94 0.27, 0.53, 0.70 
0.91 0.25, 0.53, 0.70 
attempted by reducing carboxyl-C14 labeled compound I in the presence 
of acetaldehyde and of methylamine. Three separate preparations 
of compound I from carboxyl-C14 30HAA were made. The first was reduced 
as described above at pH 7.0, the second after the addition of a 100-
fold molar excess of acetaldehyde and the third, with a 100-fold excess 
of methylamine. The products were chromatographed in the butanol: 
pyridine: water solvent and counted with the chromatogram scanner. No 
well-defined derivative with either reactant could be found . Compound 
I was, instead, again converted to piperidinedicarboxylic acid. A 
broad spot of an Rf of about 0,3 was found for the acetaldehyde 
reaction in one experiment but was lost on rechromatography and 
could not be repeated. 
b. Reaction of Compound I with Metal Ions 
Attempts were made to prepare a dioxolane derivative with 
the postulated aldehyde group. When 2 µmoles of compound I was treated with 
20 µmoles of ethylene glycol and 100 µg of ferric chloride a mixture resulted 
·having the spectral absorption shown in Fig. 19. There was nearly complete 
disappearance of the characteristic absorbance of 3€:0 mµ. But when com-
pound I was treated with ferric chloride alone an identical curve resulted. 
Figure 20 shows a time-rate study of the disappearance of compound I. 
It can be seen that the rate of decay is very rapid when the compound 
is treated with ferric ion, while the spontaneous decay rate of the 
untreated mixture is in accord with that reported for compound I (11), 
When aluminum chloride was added to the intermediate a similar response 
was observed. Table X shows the result of a microbioassay of t he 














Comp I • 
Comp I + Fe 013 O 
+ Ethylene glycol 








• Compound I 
o. 50 0 Compound I+Fe Cl 3 
















0 0 0 0 0 
0 20 40 80 
Time, Minutes 
FIGURE 20 
THE EFFECT OF FERRIC CHLORIDE AND ALUMINUM CHLORIDE 
ON THE 
RATE OF COMFDUND I DISAPPEARANCE 
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TABLE X 
MICROBIOASSAY FOR QUINOLINIC ACID (AS NICOTINIC ACID) AFTER 
ADDITION OF ALUMINUM CHLORIDE AND FERRIC CHLORIDE 
Per Cent 
Reaction Before Assay µg Quinolina te/ml of Total 
Compound I-+ QA 19.6 100 
Compound I+ AlC13 8.55 43.7 
Compound I+ FeC13 11,6 59.2 
QA + FeCl 19.6 100 
.3 
with the metal ions was not converted to quinolinic acid. The ions 
did not catalyze ring closure to quinolinate nor did they deca.rboxylate 
compound I or quinolinate to give niacin. Either the ions chelated 
with compound I preventing ring closure or they prevented qui.nolinic 
acid from being assayed as niacin. A control in which ferric chloride 
was added to a known amount of quinolinic acid resulted in a nearly 
quantitative ass~ for niacin after deca.rboxylation of quinolinate. 
Therefore, the ferric chloride did not prevent decarboxylation or 
inhibit bacterial growth in the study. It was thus concluded that 
a derivative or chelate of compound I was formed with the ions. 
A paper chromatogram of the product of the metal-compound I 
reaction was prepared. One µmole of tritium-labeled 30HAA {700 mµc) 
was oxidized to compound I and the alcoholic solution was immediately 
treated with aluminum chloride. The solution was taken to dryness 
in vacuo, applied to a paper strip and developed in the buta.nol: 
pyridine: water solvent. Three radioactive spots were found at Rf 1s 
of 0.1, 0.41, and O. 51. The areas under the curves were approximately 
one-fourth, one-fourth and one-half of the total radioactivity, 
respectively. Studies a.re presently being made to determine the 
nature of the derivative. It is possible that the complex will 
facilitate the formation of other derivatives of the aldehyde or 
amino groups. 
c. Derivatives of Compound I Produced in a Purified Sy:stem 
When a more purified enzyme preparation was obtained in later 
studies, derivatives of the aldehyde and amino group of compound I 
were attempted assuming that there would be less interference from 
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extraneous substances. Four µmole of 30HAA was oxidized to compound I 
using a minimum amount of enzyme. A total of 2. 5 mg of protein was 
needed for complete oxidation, but most of th.is was removed by the 
addition of the ethanol. This was approximately one-twentieth of the 
protein used in the experiments previously descrioed. The rate of 
disappearance of compound I was followed spectrophotometrically. 
The carbonyl reagents th.iosemicarbazide (TSC) and semicarba zide 
(SC) and the amine reagent picrolonic acid (R)A) were added to an 
aliquot of compound I in a 40:1 molar ratioofreagent to substrate 
at pH 7. 0. After 5 minutes nearly all of the absorbs.nee at 3tD m µ 
haddisappaaredin the thiosemicarbazide and semicarbazide reactions 
indicating a complete disappearance of compound I. The optical 
density of the piorolonic acid-treated reaction approached infinity 
because of the absorbance of the reagent itself at this wave ler.gth. 
Radioisotopic tracers were used to study these products 
and to>verify the formation of derivatives. Carbo:xyl-C14 30HAA 
was used to prepare compound I. If compound II or picolinic acid were 
formed in the reaction, the labeled carbo:xyl grou:r; would be lost, and 
no interfering degradation products would be detected. Only quinolinate 
and compound I derivatives would be likely to be detected by radio--
activity on a chromatogram. Four µmole (&JO mµ.c) of carboJ<Yl-c14 
compound I was prepared as before and divided into four parts . All 
reagents were added in the molar ratio of 10:1. Solvents were evaporated 
in vacuo, and the residue was chromatographed in butanol: pyridine: water 
and counted. In Table XI are recorded the results of this study. 




CHROMATOGRAMS OF DERIVATIVES FORMED FIDM 
Y-CAROOXYL-C14 COMPJUND I 
Rf Values of Radioactivity 
Reactant Butanol;pYridine:water 
Compound I QA 0.29 
TSC + Compound I 0.29, o.68, 0.85 
SC+ Compound I 0,42 
PJA + Compound I 0.48, 0.84 
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when compound I was treated with thiosemicarbazide. Semicarbazide 
caused considerable smearing of the radioaotivi ty. In both cases 
the major product:. was quinolinic acid (Rf= 0.29)., but it was 
shown that compound I reacted with these carbonyl reagents to give 
a product(s), which retained the labeled ca.rboxyl carbon. Treat-
ment with picrolonic acid resulted in two radioactive areas, but 
it is not known whether these are derivatives of quinolinic acid 
or compound I. 
d. Other Attempts to Prepare Derivatives 
The spectrophotometric detection of reactions with other 
reagents was attempted. The neutral reagents listed below were 
added to aicoholle solutions of compound I prepared by oxidation 
with an acetone powder extract, and aliquots were removed and 
diluted with water for readings. These preparations were compared with 
the same uourit of untreated compound I and the reagent alone as 
controls. Pyridoxamine, pyridoxal., acetaldelzy'de., Tollens: reagent 
and 'm:aleic ~lzy'dride failed to change the absorption ma.x:imum of 
compound I. 
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C. Metabolism of Compound I. 
The observations of Gholson. et al. (72, 73) that tritium-
labeled .30HAA gave rise to glutarate and acetate in vivo led to the 
postulation that the main route of tryptophan degradation is via 
.30HAA to compound I. The two k.no'W!l products of compound I degradation 
in vitro, quinolinic and picolinic acids1 have been shown to be 
minor products in vivo (35), and neither is metabolized to an 
appreciable extent in the whole animal (17, 34, 35). For these 
reasons it was believed that some other degradation product of 
compound I might be formed in the whole animal. The degradation of 
compound I in vitro and in vivo was investigated in an attempt 
to find an aliphatic route of metabolism. 
1. Methods 
Isolation and measurement of radioactive glutaric acid 
was done by the method of Gholson et al. (73). The Packard 
Tricarb liquid scintillation counter was used for analysis of 
the radioactivity. 
Quinolinic acid was assa;red microbiologically as nicotinic 
acid by the procedure described under Methods. 
Oxygen uptake was measured with the .~arburg respirometer. 
The various enzyme preparations were pre-incubated as described 
below for 10 minutes during which time the endogenous rates were . 
determined. One or two µmo3:es of substrate were added from the 
side arm, and readings were taken at suitable time intervals. 
Twenty per cent potassium hydroxide was used in the center well 
with a filter paper wick to absorb the COi liberated during inc~bation. 
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Pre-gassing with oxygen was not necessary, but rapid shaking during 
the reaction was important to provide sufficient exposure to the 
oxygen for this amount of substrate. 
Disappearance of compound I was followed by spectrophotometric 
measurement of the rate of decrease in the absorption at 3(:J) mµ . 
Aliquots of the reaction mixture for determination were removed at 
3-minute intervals and diluted to 3 ml in cuvettes with a one cm 
light path before measurement in the Beckman D.U spectrophotometer. 
A control preparation of compound I produced in a reaction catalyzed 
by a rat liver acetone powder extract was used to determine the 
spontaneous decay rate of the intennediate. A unit of activity of 
the enzyme which metabolizes compound I was defined as that amount 
necessary to produce an optical density decrease of 0.001 per 
minute greater than tlB. fl)Ontaneous rate of decay. 
2. Preliminary Observations 
Three isotope dilution studies were made to determine if 
small amounts of glutaric acid could be formed from 30HAA in vitro. 
(1) Rat liver slices were prepared with a Stadie-Riggs 
microtome. Five hundred mg of tissue 5 mm in thickness was incubated 
in 4 ml of .Krebs-Ringer phosphate buffer, pH 7.1. Three µc (700 µg) 
of tritium-labeled 30HAA was added, and the mixture shaken for 1 
hour on a Dubnoff metabolic incubator at 37°C and 140 cycles per 
minute. The contents were homogenized with a Po ~ter-Elvahjem 
homogenizer, and the proteins were precipitated with four volumes 
of ethanol. One--hundred mg of glutaric acid was added as carrier, 
the ethanol was evaporated in vacuo and the residue was passed through 
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a Dowex 50- (H) column 2 x 20 cm to remove amino acids, proteins 
and quinolini.c and picolinic acids. The eluant was concentrated 
· to ~ ml in vacuo, acidified and chromatographed on silicic acid 
(73). 
' ' 
The glutaric acid was detected by titration with 0.07 N 
sodium hydroxide and was ass~ed for radioactivity. 
(2) Three µc of tritium-labeled 30HAk was incubated 
with liver slices in the presence of 0.3 µmole~ of ferrous sulfate, 
1 µmole of DPN, EfJ µmol es ATP and 20 mg of glutaric acid. The 
latter component was added to inhibit metabolism of labeled 
glutarate. After 1 hour of incubation the reaction was treated 
as above, and the glutarate was isolated and counted. 
(3) Three ·µo of tritium-labeled substrate was incubated 
with 500 mg of kidney tissue as slices and 0.3 µmole ferrous sulfate, 
1 prnole DPN, EfJ µmoles of ATP and 20 mg of glutarate. The incubation 
was allowed to proceed for 1 hour, then treated as above; the 
glutarate was isolated and counted. None of the glutarate was 
found to be labeled in any experiment. 
3. Metabolism of Compound I In Vivo 
An attempt was made to observe the cpnversion of compound I 
to glutarate in the intact rat. If this intermediate ·were on the 
pathway from ))HAA to glutarate, it might be possible to detect 
.the reaction by the metabolite ove~loading technique. The major 
difficulty was to obtain enough isotopic compound I to effectively 
label the glutarate but in a small enough volume to be injected 
into a rat. This was overcome when JOHAA oxidase was prepared in 
concentrated form (Section A). Ten ~11oler (7.0 µ.c) of tritium-labeled 
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30HAA was incubated with 1. 5 ml of enzyme purified through the ammonium 
sulfate-fractionated step. The enzyme was preincubated 5 minutes with 
0.3 µmole of f errous sulfate and 3 µmol~ of glutathione before addition 
of substrate. The final solution of 4.0 ml was stirred rapidly during 
the 3 minutes necessary for the disappearance of 30HAA. An aliquot of 
the mixture was diluted with water, and the absorbance at JED mp was 
measured. The yield of compound I was 88 per cent of the theoretical 
amount. The entire mixture containing 8 mg of protein was injected 
intraperitoneaJ.ly into a 200 g. rat. Carrier glutarate . (300 mg) was 
injected immediately. The rat urine was collected over a 24-hour 
period and purified. The glutarate was isolated, counted and found to 
be unlabeled • . • 
4. Compound I Metabolism In Vitro 
a. Measurement of Compound I Metabolism by Oxygen Uptake 
The oxidation of .30HAA to compound I requires one mole of 
o:xygen per mole of substrate. It seemed feasible that a system for the 
oxidation of compound I or one of its aliphatic degradation products 
could be detected by obserV".i.ng o:xygen uptake in addition to that 
required for .30HAA oxidation. Table XII contains typical results 
obtained in a series of Warburg respirometric studies. Two µmole of 
substrate was used in all experiments. Liver slices weighing approximately 
JOO mg and 5 mm in thickness were prepared with a Stadie-Riggs microtome. 
Five-tenths ml of a 10 per cent homogenate in Krebs-Ringer phosphate 
buffer, pH 7.0 was used when called for in the reaction. Red blood 
cells were prepared from rat blood obtained by heart puncture; blood 
was withdrawn in a syringe containing oxalate and centrifuged. 
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TABLE XII> 
OXYGEN UPTAKE UPON THE OXIDATION OF 30HAA 
CATALYZED BY SEVERAL PREPARATIONS 
Tissue Preparations and Additions 
Acetone powder extract 
Acetone powder extract+ mitochondr'ia 
Acetone powder extract+ mitochondria+ ATP 
Acet·one powder extract + Red· Blood Cells 
Homogenate+ ATP, FAD, DPN 
Liver slices 









The supernatant was decanted, and the cells were washed once in 
physiological saline. The centrifuged, packed cells were suspended 
in an equal volume of saline and O. 25 ml was added to the Warburg 
vessels. Liver mitochondria were prepared in 0.25 M sucrose, 0.002 M 
Tris buffer and 0.003 M versene ·l;>y the method of Schneider (89). 
When red blood cells and mitochondria were used, O .. 5 ml of a 10 
per cent acetone powder of liver was added as a source of the 
oxidase. 
All results except those with the slices were essentially 
the same. Nearly one mole of oxygen was consumed per mole of 
substrate. Addition of cofactors affected the controls and the 
test reactions in the same manner s.o t hat a particular require-
ment could not be detected. Liver slices consistently catalyzed the 
uptake of greater amounts of oxygen than the theoretical values 
for JOHA.A oxidation, but the addition of cofactors could not be 
observed to increase the uptake. Variations were frequent in the 
assays probably because of the high amount of endogenous substrates 
in the crude preparations. 
b. Spectrophotometric Detection of the Metabolism of Compound I. 
It was decided that a more accurate measurement of compound I 
metabolism could be obtained by measuring the rate of disappearance 
of the absorption maximum at J(;D mµ. Ten per cent fresh rat liver 
aiid kidney homogenates were prepared in 0.9 per cent potassium 
chloride solution with the Potter -Elvehjem homogenizer. Compound I 
was produced by incubating 2 µmole ,, of JOHAA with o. 5 ml of the 
acetone powder extract and Krebs-Ringer buffer in a total volume 
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of 3. 0 ml. When the substrate had disappeared as determined by 
fluorometric assay, 0.1- ml aliquots from the incubation were added 
to three cuvettes, one with water, a second with 0.05 ml of l iver 
homogenate and the third with O. 0 5 ml of kidney homogenate. Figure 
21. shows that the rate of decomposition of compound I is the same 
with or without the liver homogenate. The compound I incubated 
with the kidney homogenate, however, disappeared considerably 
faster. It was assumed this was an enzymatic degradation because 
of the heat-labile nature of the catalyst. When a portion of the 
kidney homogenate was heated nearly to boiling for one minute 
all activity was lost. 
One-tenth µmole of each of the following components 
was added to individual incubation mixtures before addition of 
compound I to determine whether the newly-found enzyme required 
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a cofactor and, therefore, to define the type of reaction: flavin 
mononucleotide (:FMN), flavin adenine dinucleotide (FAD}, diphosphopyridine 
nicleotide,, (DPN) triphosphopyridine nucleotide (TPN), thiamine 
pyrophosphate (TPP), pyridoxal phosphate (Bl) and coenzyme A 
(Co A). Both liver and kidney homogenates were tested. It is 
seen from Fig. 22 and Fig. 23 that none of the cofactors had any 
effect with either liver or kidney tissue. The half-life of compound I 
in the presence of the kidney with or without the cofactors was, 
again, noticeably less than in the presence of the extract or liver 
homogenate. 
c. Product of Metabolism of Compound I in Kidney 
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FIGURE 21 
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Readings were taken at 5 minute intervals. 
FIGURE 22 
RA.TE OF COMRHJND I DISAPPEARANCE 
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2. Homogenate+ FMN 
3. Homogenate + FAD 
4. Homogenate + TPN 
5. Homogenate + DPN 
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Readings were taken at 5 minute intervals. 
FIGURE 23 
RATE OF COMroUND I DISAPPEARANCE 




liver extracts and homogenates and by kidney homogenates was assayed 
microbiologically . The kidney as well as the liver contains 30HAA 
oxidase (40, 41) so that compound I was produced in situ for the 
three preparations examined. Two µmole of 30HAA was incubated with 
0, 5 ml of 10 per cent preparations in 3 ml of Krebs-Ringer buff er 
for one hour. The preparations from the acetone powder extract, 
liver homogenate and kidney homogenate contained 89, 78 and 32 
per cent of the theoretical amount of quinolinic acid, respecti. vely 
(Table XIII). These data confirmed the presence of an enzyme in 
the kidney which degraded compound I to a product or intermediate 
other than quinolinic acid or nicotinic acid. 
The enzyme of the kidney preparation metabolizing compound I 
was found in the 21,000 xg supernatant of the homogenate and was 
sensitive to cyanide at 10-3 M. An isotope dilution study was 
made to determine if the product of this reaction were picolinic 
acid. Tritium-labeled 30HAA was converted to compound I using a 
liver acetone powder extract. The incubation mixture was divided 
into two portions; 0. 5 ml of the kidney supernatant was added to 
one part. After one hour of incubation the reactions were treated 
with four volumes of absolute ethanol. An aliquot was removed · 
from each for microbiological assa;r. One ,hundred mg of quinolinic, 
picolinic and niootinic acids were added as carrier; reisolated, 
purified and assa;red for radioactivity as described in section B. 
The results of this study are contained in Table XIV. No nicotinate 
was found. A substantial. amount of the isotope in the kidney-
treated preparation was isolated as picolinic acid. Much of the 
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TABLE XIII 
MICROBIOASSAY FOR QUINOLINIC (NICOTINIC) ACID PRODUCED 
IN THREE ENZYME PREPARATIONS 
Preparation 
Rat liver acetone powder 
Extract (10 per cent) 
Liver homogenate 
(10 per cent) 
Kidney homogenate 
(10 per cent) 
Per cent 






ISOTOPE DILUTION STUDY OF THE AMOUNT OF PYRIDINE C:ARBOXYLIC ACIDS 
PRODUCED IN A RAr LIVER ACETONE POWDER 
EXTRACT AND A KIDNEY HOMOGENATE 
Acetone Powder Ext.Kidney Homogenate 
of Substrate Appearing as:. Isotope M.B.A, Isotope M,B,A, 
Quinolinic Acid 31.0 87.0 15.0 .39.0 
Picolinlc Acid 2.3 fil5.s 21.0 3 53 .o 
Nicotinic Acid 0 0 
Product Accounted for 33.3 92.8 36.o 92.0 
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3 Correction for loss of isotope based on comparison of isotope in 
quinolinic acid.!§. growth activity of decarboxylated quinolinate = 
2.5. 
t r itium was unaccounted for, but this was probably lost by exchange. 
It i s no-:te..ble t hat, though the isotope dilution method indicated 
only 31 per cent quinolinic aci d, microbioassay showed that there 
was 87 per cent of the acid pr oduced in t he liver-catalyzed r eaction. 
Similarly, the microbioasaay demonstrated that the reaction incubated 
with the kidney supernatant contained two and one-half times more 
quinolinic acid as found by isotope dilution. If the value obtained 
by isotope dilution for picolinic acid is increased by two and 
one-half times to correct for the exchange of tritium, there would 
be a yield of 53 per cent picolinic acid in the kidney incubation, 
and 92 per cent of the product would be accounted for. It i s 
possible that the major product of compound I degradation in the 
kidney preparation is picolinic acid. 
d. Metabolism of Compound I as Determined by Microbiological 
Asse.y for Quinolinic Acid. 
It was apparent from the previous observations that a 
more sensitive method for the identification of an en~e system 
that degrades compound I was ne~essary because of the high endogenous 
rates obtained in the Warburg studies, the isotope loss in tracer 
studies and the slight or no change in rate of compound I degradation 
determined spectrophotometrically. A final difference in the quantity 
of quinolinic acid between a control and a test reaction with a 
cofactor should be easier to detect than the change in the r ate 
of formation of this product at this early stage of investigation. 
The amount of quinolinic acid produced in a reaction catalyzed by 
a rat liver acetone powder extra.ct or rat liver homogenate was taken 
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as standard; a decrease in quinolina~e produced in an incubation with 
a cofactor was .taken as ·indication of enzyme activity. Table XV 
summarizes the results.of three different experiments. Twenty 
per cent rat liver homogenates were incubated. with 2 µmoles of 
30HAA in Krebs-Ringer buffer.·. En;dogenous niacin activity was 
. . 
determined in an aliquot of the reaction ¢xture removed before 
addition of substrate. The cofactors shown were added to different 
reaction;:: mixtures ·prior to .substrate addition. After incubation 
with shaking at 140 cycles _per minute for 2 hours at 37"C, the 
reactions were stopped by addition of four volumes of ethanol. 
An aliquot from each and aliquots from the controls were decarbo:xylated 
to niacin for microbiological assq by autoclaving with glacial 
acetic acid. · Column. 2 of · Table XV shows the average of the data 
of two experiments designed to determine the result of combining 
the cofactors most effective in reducing the quinolinio acid 
yield in the study reported in colt'lJSln 1. When FMN and DPN were 
added separately there were 19 and 13 per cent respectively less 
quinolinate produced compared to control fiasks. When the 
cofactors were combined in an incubation there was 35 per cent 
less quinolinate than in.the control homogenate Showing a comple-





EFFECT OF VARIOUS COFACTORS ON THE AMOUN:T OF QUINOLINIC ACID 
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A. 3-Hy:droxyanthranilic'" Acid Oxida§e 
The study· of the purification o'f 30HAA oxidase has un-. 
oovered several unusual characteristics. Despite earlier reports 
to the co~trary, the enzyme is very stable. ~an be heated t;;--==--~----~---·--,·--~-
55 •c for five minutes. It c&ll be stored for two months with no 
loss in activity. It is not only- stable to acid and base treat-
ment for short periods of time but ia activated by these treatments. 
The presence of an ionic environment also causes a stimulation in 
activity-. Ferrous ions are required tor mmmum activity, and 
glutathione will restore and maintain activity- in aged preparations 
provided the enzyme is preincubated with ferrous ions before 
assay. 
Two basic questions are apparent: (1) what is the mechanism 
of action of the activators, (2) what are the functional groups of 
the so-called "active site"? Some of the observations made suggest 
answers to these questions. 
Each activator could. affect the enzyme in a different 
wa;y and in sequence resulting in several different forms of the 
enzyme. However, it has not been established for certain that amy 
two of these activators do not have the same function. There is 
evidence for a prefe~ed sequence of addition. It seems likely that 
the ionic environment affects the en~e before iron is added. 
as 
89 
When the enzyme has been purified and activated with acid and base 
the ionic effect of addition of ammonium sulfate is not always 
observed. The acid or base activation is therefore probably related 
in some way to the salt activation. The primary difference between 
ammonium. .sulfate and acid activation is that the acid has a more 
permanent, holding effect; after neutralization the enzyme is still 
activated. Ammonium sulfate must be added to the enzyme 5 minutes 
before assay to obtain maximum activity. 
Treatment with base not only activates the crude enzyme 
but also restores activity that has been lost through aging of the 
acid-treated or ammonium. sulfate fractions of the enzyme. It 
would seem that acid and base are functioning in a different manner. 
The alkali could restore some lost configuration (or negativity) 
to the inactive enzyme. 
After preparation of several batches of the enzyme it 
became obvious that the amount of oxidase activity in homogenates 
differed widely from one prepaI'ation to another. In all cases 
treatment with acid produced a marked stimulation, and the ru::tivity 
per gram of tissue was of the same order in each preparation. If the 
crude enzyme were 0masked11 in some manner by intramolecular folding 
by a peptide or as a pro-enzyme in an intermolecular complex. 
then acid would cause a partial denaturation; the groups of forces could 
be considered as unstable to acid and would be released during treatment. 
The activation by ferrous ion and glutathione are probably 
not occurring in the same manner as acid, base or salt 
activation. No other activator will replace it (46). In all stages 
of purification ferrous ion is required for maximum actiyity • . However, 
if substrate is added before ferrous ion preincubation, the enz~e 
is not acti"f8.ted by the ion. This suggests that the ferrous ion is 
a cofactor bound to the enzyme at or near the active state. 
Glutathione does not activate at all times. Fresh 
preparations !of enzyme often have as JlD.lCh activity without reduced 
glutathione addition. This is not surprising since sulfhydryl 
groups of proteins are likely to be slowly oxidized at pH 7.0. 
It is conceiyable that another functional group involved in catalysis 
is a sulfhydryl group. The fact that JOHAA has a protecting influence 
on the enzyme in the presence of pCMB indicates that the sulfhydryl 
group could be at the active site. It has been reported that high 
concentrations of glutathione (10-2M) inhibit the enzyme. If some 
disulfide bonds were essential in maintaining the configuration of 
the protein this wou+d also be expected. 
All of the activators affect the "actiTe site". Howeyer, 
to limit the definition of active site to two or three peptides 
bonds which are influenced by these actiTators seems incorrect. 
Most likely the secondary and tertiary structures of the enzyme 
play as much of a role as the actual binding sites in its activit7 
and specificity. 
A possible scheme to explain the activation discussed is 
shown in Fig. 24.' An ionic environment partially exposes the 
act ive site, while acid and base af f ect the enzyme in a similar 





PBOroSED SCHEME OF .30HAA OXIDASE ACTIVATION 
The base also restores an internal negativity necessary for binding 
of iron. Ferrous ion is then bound, and the enzyme is in its most 
active state. 
There are at least .31 forms theoretically possible when 
all five activating factors are considered. Many of these are active. 
Until more information is obtained concerning the effects of the 
activators these forms cannot be eliminated. 
B. Structure of ComDQ£.tl_g_j, 
Compound I is probably formed from the oxidative cleavage 
of 30HAA in the J-,4 position of the benzene nucleus giving rise to 
the structure shown in Fig. 2. Molecular o:xygen is required for 
this oxidation. There is no evidence to support a two-step 
oxidation as suggested by Miyake et.~. (42) and Snell (65). Also, 
until now 3 little direct evidence to support the structure of compound 
I as shown has been presented. In order for quinolinic acid to 
result from JOilliA oxidation this structure seems likely, 'I'here 
are several reasons why characterization of this compound has 
been difficult: (1) only small amounts of product could be formed 
very easily; that which couJ.d be produced in an enz;yme=catalyzed 
reaction has been a minor component of the mixtu.:r:ue a,s a whole, 
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(2) the product is unstable even llllder the best conditions and 
particularly in acid, which is usually favorable for carbonyl reactiarrn 3 
(3) the molecule might be sterically hindered because of the un-
saturation, end the close proximity of the postulated aldehyde and 
amino groups could prevent the formation of derivatives. 
Attempts to reduce the molecuJ.e and thereby lessen the 
steric effect have been shown, instead, to catalyze the condensation 
between the aldehyde and amine as well. It is probable that reduction 
of the double bonds occurs 1 at least in part, before condensation 
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of the carbonyl and amino groups. If condensation occurred first 
quinolinic acid would be for.med. This acid was found not to be 
reduced at pH 7.0 in 80 per cent ethanol in the conditions used for 
these reduction experiments. However the fact that aldehydes and 
amines do react under conditions of reduction is in accord with several 
reports (66,90). 
The observations of Wiss and Bettendorf (58) that com-
pound I reacts with carbonyl reagents are questioned here in 
view of the effect of acid (i.e., TCA) on the intermediate. The 
conditions for the precipitation of proteins in their studies were 
such that compound I would be converted to compound II. Long (ED) 
reported that a deamination occurs upon treatment of compound I 
with acid resulting in a product which is sensitive to carbonyl 
reagents. Studies here and elsewhere (ED) indicate that compound 
I is also decarbozylated by acid3 perhaps making compound II less 
hindered. 
Wiss ( 62) later reported that picolinic acid results 
from acid treatment rather than enzymatically9 as shown by Mehler 
(33) and others (35). In an isotope tracer experiment this acid 
conversion to picolinic acid could not be confirmed. These studies 
were done using tritium=labeled substrate. It should be noted 
that posslbly some of' the isotope is lost when. compound I is formed. 
As was observed in section 3 a m.:Lcrobioassay showed that there was 
twice as much acid formed from compound I as the isotope data 
would suggest because of the exchange of tritium with the medium. 
This fact must be considered when quantitative determinations with 
this isotope are made. 
There were four reagents which gave derivatives of 
compound I: (1) metal ions, (2) thiosemicarbazide 9 (3) semi= 
carbazide and (4) picrolonic acid. The complex or chelate 
formed with the metal ions does not provide evidence concerning 
a:ny specific functional group. It may facilitate the formation of 
other derivatives, however, by preventing the spontaneous deca;r of 
compound I to quinolinic acid. Semicarbazide and picrolonic acid 
appeared to react with compound I, but the most encouraging results 
were obtained with thiosemicarbazide. All r.eagents formed compounds 
which gave radioactive spots on a chromatogram different from that 
of quinolinic acid. Since carboxyl-labeled compound I was used 
these were not derivatives of com.pound II, a product known to 
react with carbonyl reagents. The results can then be interpreted to 
mean that true derivatives of compound I were fomed under the 
conditions of this experiment. 
C. Metabolism. of Compound I 
The observations of Gholson, sdi, al. (723 73) that tryptophan-
7a-C14 and tritium-labeled .30HAA give rise to labeled glutarate in 
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the intact rat strongly suggest that the main route of 30HAA metabolism 
is via compound I. The pyridinecarbo:xylic acids are not metabolized 
appreciably so that it is probable that compound I is degraded to 
some aliphatic product before ring closure. The fact that compound I 
is converted to picolinic and quinolinic acids in nt.r.o indicates 
that the enzym.ic oxidation or deamination is slow or inhibited and 
ring closure occurs first. 
The preliminary experiments did not reveal an enzyme system 
which converts compound I to glutarate in vitro. The tritium-labeled 
intermediate did not label gluta.rate in vivo. Neither experiment 
provided substantial evidence against its role as an intermediate, 
however. Compound I can condense to quinolinate before further 
metabolism can. occur., and exogenous compound I may not equilibrate 
with that formed endogenously. 
There are undoubtably numerous enzymatic reactions between 
compound I and glutarate. Before products can be identified it 
is necessary to detect a system for the metabolism of compound I. 
The tissue sources for this system were the liver and kidney since 
both contain 30HAA oxidase activity. Three methods of assay were 
employed. Oxygen uptake measurements a.re ineffective under the 
conditions em.ployed because of the high endogenous rates observed 
and because it is not known that the first step is an oxidative 
one. Nevertheless, if oxidation were observed in the preparation 
of compound I it would be apparent that metabolism of compound I 
were occurring regardless of which reaction were oxidative. 
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The use of a spectrohotometric assay to measure the rate of disappear-
ance of the absorption max:imu.m. at 360 mµ. is difficult because, until the 
system and its requirements can be definedj the enzymatic rate 
will be so slight that it will not be distinguishable from the 
spontaneous rate or from picolinic carbo:xylase activity. Never-
theless, it is a quick assay that may be useful in later studies. 
96 
The best method found in these investigations was the measure of 
the final amount of quinolinic acid; the faster the rate of enzymatic 
decomposition of compound I, the less quinolinate will be found. 
If addition of a cofactor affects the amount of quinolinic acid 
formed, then the structure of a second product might be protosed 
based on the nature of the reaction in which the particular co-
enzyme participates. The fact that dipb~~i::y~idine nucleotide 
and flavin mononucleotide caused a 35 per cent decrease in quinolinate 
suggests that there are two reactions, an oxidation and a deamination, 
occurring, since the cofactors are commonly required for these reactions. 
The detection of picolinic carbo:xylase activity in rat 
kidney recalls the question of its function. Picolinic acid is a 
minor excretory product in rat and this compound is not metabolized. 
One can only postulate that this enzyme produces an intermediate 
that is attacked by other enzymes in the aliphatic degradation to 
gl utarate, oxidizing or deaminating it. In view of these above 
data, the sequence of reactions below seems quite logical: 
(l[COOH -CO () -NH Hn=O DPN+ 3 > H NH :,,i +H 0 H NH 2 
O COOH 2 O COOH 2 FMN OH 
~=~ ~ C'1ooH 
COOR 
FIGURE 25 
PIDroSED PArHWAY OF COMroUND I METAOOLISM 
The above studies are essentially preliminary investigations 
to determine a system for study of the further metabolism of compound I 
and to obtain a suitable method of a.ssey. 
A loss of tritium has been repeatedly observed throughout 
the entire studies when tritium-labeled .30HAA is converted to quinolinic 
acid. This loss is probably the result of an exchange of the tritium 
97 
from labile positions on compound I with the medium. .3-Hydro:xyanthranilic 
acid is labeled in three positions on the ring by the Wilzba.ch method,(18) 
but there is no evidence that uniform labeling occurs; in fact, 
because of the influence of the various functional groups one would 
not expect uniform labeling. Exchange could occur from only one 
position after oxidation of substrate, but still, a loss of more 
(or less) than one-third of the isotope might be observed. Because 
of this loss in radioactivity., whatever the reason may be, tritium.-
labeled JOHAA cannot be used as a quantitative tool without correction 
being made for the loss. 
V. SUMMARY 
The metabolic fate of 3-hydroxyanthranilic acid was studied. 
The specific actiTity of the enzyme that catalyzes oxidation of the 
benzene ring was increased 2,000 fold. During fractionation of the 
enzyme there was approximately a 200-fold r emoTal of protein and a 
10-fold stimulation in activity by acid and base. An ionic enTironment, 
(B.1111onium sulfate),ferrous ions and glutathione are required for 
maximum activity. An ordered reaction sequence of 8.Jll2onium sulfate and 
ferrous ions with the enzyme has been demonstrated; in this the 
ammoniwn sulfate appeared to react first. 
The product of the oxidation of 3-hydroxyanthranilic 
acid, co pound I, was shown to be decarbo:x:ylated and deaminated in 
the presence of trichloroacetic acid. When the purified enzyme 
was used to prepare compound I and when alcohol was employed for 
the precipitation of proteins, the intermediate was observed to 
react with semicarbazide, thiosemicarbazide and picrolonic acid, 
indicating the pr esence of a carbonyl and an amino group en the 
molecule • 
.An enzyme in r at kidney was identified which catalyzed 
the disappearance of compound I . This enzyme was i dentified as 
picolinic carboxylase by i sotopic tracer studies . Addition of the 
cofactors diphosphopyridine nucl eotide and flavin mononucleotide to 
rat liver homogenates caused-a decrease in the final concentration 
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of quinolinic acid. This suggests that the cofactors are stimulating 
the action of other enzymes which metabolize compound I. 
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